AnalystsInsight

Julian Harrison (BTIG): Analyst Track Record and Price‑Target Accuracy

Julian Harrison is one of the top‑ranked analysts in Exent’s 7‑year backtest. What Julian covers, how Julian’s ratings lean, how fast price targets were reached and the ratings from before the last 30 days; the full record and the newest calls are members‑only.

Reviewed by:David, Senior AnalystPublished Oct 22, 2026Updated Oct 22, 20262 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

+5 new ratings (stocks members‑only)

Key takeaways

Julian Harrison ranks among the top 50 healthcare analysts in Exent’s ranking, scored on a 7‑year backtest.
The exact rank, price‑target hit rate and live calls are members‑only in Exent Gems.
Julian published 13 ratings in the last 30 days, the latest on Oct 20, 2026.
Most‑covered stocks: CGEM, APGE, NKTR, SYRE.
In the past year Julian’s ratings were 98% Buy, 2% Hold and 0% Sell.

In this article

Julian Harrison’s track record at a glance
How fast price targets were reached
Stocks Julian Harrison covers most
Julian Harrison’s latest ratings
How Exent scores analysts

Julian Harrison’s track record at a glance

Julian Harrison of BTIG ranks among the top 50 healthcare analysts in Exent’s ranking, with a focus on healthcare. The top of the ranking is what Exent Gems follows, so Julian’s exact rank, hit rate and live calls are for members.

Metric	Julian Harrison	All analysts
Exent rank		—
Price‑target hit rate		53.6%
Calls up after 12 months		64.6%
Median 12‑month return of calls		+13.4%
Median days to hit target		91 days
Stocks covered	39	—

Unlock the full record in Gems

How fast price targets were reached

Time to reach the target	Julian Harrison
Under 30 days	9.6%
30–90 days	19.9%
90–180 days	22.9%
Over 180 days	47.5%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Julian Harrison covers most

CGEM · APGE · NKTR · SYRE · ORKA · ABVX · AKBA · MLTX

In the past year Julian’s ratings were 98% Buy, 2% Hold and 0% Sell.

Julian Harrison’s latest ratings

Date	Stock	Action	Rating	Price target
Oct 20, 2026
Oct 19, 2026
Oct 15, 2026
Oct 14, 2026
Oct 9, 2026
Sep 22, 2026	ABVX	Reiterated: Buy	Buy	$175.00
Sep 22, 2026	MAZE	Reiterated: Buy	Buy	$46.00
Sep 17, 2026	NKTR	Reiterated: Buy	Buy	$178.00
Sep 14, 2026	AKBA	Reiterated: Buy	Buy	$4.00
Sep 14, 2026	CGEM	Reiterated: Buy	Buy	$40.00
Sep 3, 2026	CLYM	Reiterated: Buy	Buy	$32.00
Aug 27, 2026	CNTB	Reiterated: Buy	Buy	$10.00
Aug 26, 2026	SYRE	Rated: Buy	Buy	$121.00
Aug 19, 2026	TVRD	Reiterated: Buy	Buy	$5.00
Aug 14, 2026	TVRD	Reiterated: Buy	Buy	$5.00
Aug 14, 2026	OTLK	Reiterated: Buy	Buy	$4.00
Aug 13, 2026	NKTR	Reiterated: Buy	Buy	$178.00

Oct 20, 2026
Stock
Action
Rating
Price target
Oct 19, 2026
Stock
Action
Rating
Price target
Oct 15, 2026
Stock
Action
Rating
Price target
Oct 14, 2026
Stock
Action
Rating
Price target
Oct 9, 2026
Stock
Action
Rating
Price target
Sep 22, 2026
Stock
ABVX
Action
Reiterated: Buy
Rating
Buy
Price target
$175.00
Sep 22, 2026
Stock
MAZE
Action
Reiterated: Buy
Rating
Buy
Price target
$46.00
Sep 17, 2026
Stock
NKTR
Action
Reiterated: Buy
Rating
Buy
Price target
$178.00
Sep 14, 2026
Stock
AKBA
Action
Reiterated: Buy
Rating
Buy
Price target
$4.00
Sep 14, 2026
Stock
CGEM
Action
Reiterated: Buy
Rating
Buy
Price target
$40.00
Sep 3, 2026
Stock
CLYM
Action
Reiterated: Buy
Rating
Buy
Price target
$32.00
Aug 27, 2026
Stock
CNTB
Action
Reiterated: Buy
Rating
Buy
Price target
$10.00
Aug 26, 2026
Stock
SYRE
Action
Rated: Buy
Rating
Buy
Price target
$121.00
Aug 19, 2026
Stock
TVRD
Action
Reiterated: Buy
Rating
Buy
Price target
$5.00
Aug 14, 2026
Stock
TVRD
Action
Reiterated: Buy
Rating
Buy
Price target
$5.00
Aug 14, 2026
Stock
OTLK
Action
Reiterated: Buy
Rating
Buy
Price target
$4.00
Aug 13, 2026
Stock
NKTR
Action
Reiterated: Buy
Rating
Buy
Price target
$178.00

Julian published 13 ratings in the last 30 days, the latest on Oct 20, 2026. Ratings from the last 30 days are members‑only in Exent Gems, with the stocks where several top‑ranked analysts agree; older ratings are shown in full.

See the latest ratings in Gems

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Oct 20, 2026; ranking updated Oct 22, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

Exent Gems shows Julian Harrison’s full record and latest ratings, without the 30‑day delay.
Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

See this week’s Gems

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring, Julian Harrison ranks among the top 50 healthcare analysts in Exent’s ranking, based on a 7-year backtest of price-target hit rate, returns after calls and number of ratings. The exact rank, hit rate and live calls are members-only in Exent Gems (exent.ai/radar). Past accuracy does not guarantee future accuracy.

Julian Harrison’s price-target hit rate is part of the members-only record in Exent Gems (exent.ai/radar). For comparison, the average analyst’s price targets were reached 53.6% of the time.

Julian Harrison (BTIG) covers 39 stocks, mostly in healthcare. The most frequently rated are CGEM, APGE, NKTR, SYRE, ORKA.

: .-++++=: .-=+**+-. .:=+*#*=:..::-+##*+-:. .-+**+++=:. .:::-=+**********++===++***+++*###*+=--:. .:==+*#*+-:..::-+##*+-:. :=**++=: .-=+**+-. .:=+*#*-...: . -++*+=: .:=+**+-. .:-+*#*=:..::=+##*=-:...:=***++=:. .:-=+*###*++==--:::::::...:---==+*##**++=-. .:-=+###*=-:...-+**++=: :=++*+-. :-=***=:..:-=*##+-..: :=+*++-. :=++*+=. :-=*#*+-..::=+##*=-:...-+*#*+=-. :-=+*###*+=--:. .... .::..:-=+++****=-:..::-=*#*+=-: .-=++++=. .-=+**+-...:=+##*=:.::-+##*=::. .-++++=: .-=+**=: .-=+*#+-...:-+##*=-::.:-+##*+=:. .-=++***+=-:::.. ..:-----:::::::. .:-=+*###*=-:.. :=+**++-. .-=+**+-. .:-+*##+:..:-=*##+-:..:=*#*+-:. :=+*++-. :=+**+-. .:=+*#*-...:-+*##+-:.::-+##*=-:. :=++**++-:...::::-==+++++****++===-:....:::-+*#*+==:. .-=+**+-. .:-=*##+-:.::-+##*=::.:-+##*=-:..-+#*+=:. .-++++=: .-++**=: :-=***=:..:-=*##+-:.::-+##*=-:...:=***++-: .:-==*###**+**####*******+=-::...:-+**++=-. :-=+##*-:..:-+###+-:..:=*#*+-:..:=*#*=-: :=**+=-. :=++++-. :=+**+-. .-=+**+-...-=+##*-:.::-+##*=-:...-+***+=-. .:-=+*####*+==========++*###*+=-:. .-=+***+-...:-=*##+-::.:-*##+=-:..-+#*+=-. .-+**+=: .-++++=: :=+*+=: .-=+**=: :-+***=: .:-+*#*=:..:-+###+-::.:-+##*=-:. .-=++****+---::. .::::--+****++=-. .:-+*##+-::.:-+##*=-:..:=*#*+-: .=**++-. :=+*++-. :=+**+: -++*+=. :=+**+-. .-=+**+-..:-=*##+-..:-=*##+-::.:-+##*=-:. :=+++*++-:...:.. ...:.. .:-=+**#*=:..::-+##*+-:...-+#*+=-. -+**+=: .-++*+=: .-++*+=. :=+**+- =+**+- .-=+**=: :-=*#*=:..:-+*#*=:.::-+##*=::.:-+##*=-:. .-+**++=-: .::---====---:. .::-=*##*=-:...-+##+=-: :=+*++-. .=++++-. :=+**+-. .-=+**+: .:-=*#*= =+**=: :-=***=. .:=+*#+-..:-=*##+-..:-=*##+-:.::=*##+-:...-+**++=:. .:-==+*###*+++++=-:..:::=*##*=-:. .-+**+=: -=+*+=: .-=+**=: :-=*#*=. .:=+*#+-..:-=*##+ =+**=. .:=+**+-. .-=*##+:..:-+*#*=:.::-+##*-::::=*##+=::..-+##*=-: :-=++*###**+++*###*=-::. .-+**+=-. :=++*+=. :-+**+-. .:=+*#+-..:-=*##+:..:-+##*=:.::=*##+ +**+-. .-=+**+:..:-+*#*=:..:=+##+-:.:-=*##+-:.:-+##*=-:..:+*#*=-:. .:=++***+=------=+*##*+=-. .-++*+=: .-=+**+: .-=*#*=:..:-+*#*=:.::=*##+-:.:-+##*=::.:-*##+ +**+-. :-=*#*=:..:-+##*-..:-=*##+-:.:-+##*=::.:-*##+-:..:=*#*+-:. .-+**++=-:. ..:...:-=+*++=-. :-+***=. .:-+*#*-...:=+##+-..:-=*#*=::::-+##+-::.:=*#*=-:..-+##+ +*#+:..:-+*#*=:..:=*##+-:.:-+##*=::::-*##+-:..:=*#*=-:..:+##+=-. .:+**++-: .::::. :-++**+:. .-=+##+:..:-=*#*=:..:-+##*-::::=*##+-:.:-+##*=::.:=*#*+-:..:+##+ *##+:..:-+##*-:.::=*##+-:::-+##*=::.:=*##+-:..-+##*=-...-*#*+-:. .=***+-: :-====-: .:-+*#*=:..:-+##*-:.::=*##+-:.:-+##*=::.:=*##+-:..:+##+=-...-*#*+-:. :+**+ *##=:..:-+##*-:.::=*##=-:.:-+##+-:..:=*#*=-:..-+##+=:. :=*#*=-: :+**+=:. .-=++**#*+-..:-=*##+-:.:-+##*=::.:=*##+-:..:+##*=-:..-*#*+-:..:+**+=-. .-***+-: :=**+ *##=::::-+##+-::::=##*=-:.:-*##+-:..:=##*=-:..-+#*+-:. :=**+=-. .-+**+=: :=+*+++##*=::::=*##+-:.::+##*=-:.:-*##+-:..:+##*=-...-*#*+-: :=**+=-. .-+*++-. :=+*+ ##*=::.:-*##+-:..:=##*=-:..-*#*+-:..:=*#+=-. .-+**+-: :=**+=-. .-+*++=. :=++++*##*=::.:=*##+-:..:+##*=-:..-*#*+-:..:+**+=-. .-***+-: :=**+=: .-+*++-. :=+++ ##*=-:..-*##+-:..:=*#*=-...-+#*+-:. :=**+=-. .-+**+=: .=+*+=-. -=+*+=: .-=+*###*=-:..:=*#*=-:..-+##+=:...=*#*=-: :+**+=:. .-+*++-. :=**+=: .-++++-. :=+** ##*=-:..-+#*+-:. :=**+=-. .-+**+=: .=**+=-. :++++=: .-++*+-. :=+**+-. .:--=++=-:::.:-*##+=:...-*#*+-:. :=**+=-. -+**+=: .=+*+=-. :=+++=: .-++*+-. .-=+** *#*=-: .-+**+=:. .=**+=-. :+**+=: .-++++-. :=+**+: .-=+**=: :-=+##+-:...........::-+##*=-:..:=*#*=-. :+**+=:. .-+*++-. :=+*+=- .-++*+=. :=+**+- .-=+** ***=-. :+**+=: .-+*++-. :=+++=: .-=+*+=. :-+**+-. .:=+*#*-:..:-+*##*=--:. .:--=*##*=-:...-*#*+=:. .-+**+-: .=+*+=-. :=+*+=: .-++*+-. :=+**+: :-=*** +*++-. :=+*+=: .-++*+=. :=+**+-. .:=+**+: :-=*#*+:..:-=*##+-::.:-=*##*+==------==+*##*=-:...-+##+=-. :+**+=-. :++*+=: .-++*+=. :=+**+-. .-=+**=: .:-+*#* ++++=: :=++*+-. .:=+**=: .-=***=. .:-+*#*-...:=+##*=::::-+##*+-:.. .-++++**##***++**#*+-::..:-+##*=-:. .=***+=: .-+*++-. :=++*+-. .-=+**+: :-=*#*=. .:=+##+ =+*+=: .-++**=. .:=+**+-. .-=+##+-..:-=*##+-:.:-=*##+-:...-+##*+=:. .:-==+*###**++++=-:..:::=*##*=-:. .-+**+=:. :=+*+=: .-=+**=: .-=***=. .:=+*#+-..:-=*##+ =+**+-. .-=+**=:..:-+*#*=:..:-+##*=:.::-+##*=::..-+##*=-:. .-++*+++-: .::::--====--:. .::-+*##*=-:. .-+**+=-. :=+*++-. :=++*+-. .:=+**+-. .-=+##+:..:-+*#*= -+*#*=...:=+##+-..:-=*##+-:.:-=###+-:..:=*#*+-:. .-+**+=-. .:=++*#*+-:::.. .::.. .:--=+###*=-:...-+**+=-: .-+*++=: .-=+**=: .-=+**=: .:-+*#*=:..:=+##*- -=*##=:..:-+##*=::::-+##*=::..-*##+=-. .-+**+=-. .-++**+-. .:-=*###*+=--:.....:::..:--=++*##*+-::..:-+##*=-: .-+**+=-. :=+**+-. .:=+*#+-...-=+##+-..:-=*##+- :=*##+-::::=*##+-:..:=*#*=-:. :=***+-: .-++++=-. :-=+*#*=:..:::-=****++*+++======++********=-:..::-=*##*=-:. .-+**++-. .-++**=: :-=***=:..:-=*#*=:..:-+##*=: :-+##*=-:..-+##+=-. .-+**+=:. :++*++-. :-++**+-. .:-=*##*+--:. .:==++*####**++*####**++==:. .:--+###*=-:. .-+**++-: .-=+**+: .-=+*#+-...-=+##+-..:-=*##+-: .:=*#*=-:. :=**+=-: :=+*++-. .-=+**+:. .:-+*##+-:::::=+##*+=-:. .:--==+**++++****+==--: :--=*###+=-:...-+**++-: .-=+**+-. :-+***=:..:-+*#*=:..:-+##*=:: .-+**+=:. .-+**+=: .-=+**+-. .:-+*#*+:..::-+###+=-:. .:=+***++=-:........::-----::::::.. :-==+*##*=-::..:=*#*+=-: .:=++++-. :-=+**+:..:-=*##+-..:-=*##+-:: :=+*++-. :=++*+=. :-=***+-..::=+##*=-::.:-+*#*+=-: :-=+*###*+=--:. ..:. .:::::-=+++****=-:..::-=*##+=-:. .-=+*++=: .-=+**+-. .:=+##*=:.::-+##*=::. .-=+**=: .-=+**+-...:-+##*=-::::=*##*=-:. .:=+*+++=:. .::-=+*##**++==--::::::...::---=+**#**+++=:. ..:-=+###+=-:. .-+**++=: .-=+**+-. .:-+*#*=:..:-=*##+-::: . :-+***=:..:-=*##+-:.::=*##*=-:..:-+**+=-: :-=+*#*+=:::...:-=++++*###**++=+++++++++**###*+==-:. .:-=+*##*+-::...-+**++-: .:=+**+=. :-=*##+-..::=*##*-::.:

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Insight

Are Analyst Price Targets Accurate? 7 Years of Data

How often Wall Street price targets are reached, how long it takes, and how the promised upside compares with what stocks actually did. From Exent’s backtest of 628,792 analyst ratings.

Oct 16, 2026 · 7 min read

Guide

How to Follow Wall Street Analysts the Smart Way: Track Records, Not Headlines

“Analyst upgrades stock” tells you almost nothing. Who made the call, and how often they have been right, tells you a lot. Here is how to follow the analysts worth following, and what the evidence says about doing it.

Oct 12, 2026 · 7 min read

Guide

What Are Exent Gems? Top‑Analyst Agreement Explained

Gems are stocks where several of Wall Street’s best-rated analysts agree. Here is what analyst convergence means, how a stock becomes a Gem, what the data behind it shows, and where its limits are.

Oct 12, 2026 · 6 min read

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.